“…A cutoff of >3 cm lesion size is commonly used, with some authors suggesting resection of all residual lesions >3 cm [3,4,8,19,20]. This strategy, however, results in overtreatment of nearly 60% of patients, as viable cancer cells are reported to be found only in 30–50% (37.5% in our study) of residuals >3 cm [4,5,7,21,22,23]. Still, De Santis et al [15] consider, based on their results and review of other studies, surgery to be the treatment of choice for residuals with a high risk of relapse, with more favorable results than surveillance.…”